NO20063309L - Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt - Google Patents

Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt

Info

Publication number
NO20063309L
NO20063309L NO20063309A NO20063309A NO20063309L NO 20063309 L NO20063309 L NO 20063309L NO 20063309 A NO20063309 A NO 20063309A NO 20063309 A NO20063309 A NO 20063309A NO 20063309 L NO20063309 L NO 20063309L
Authority
NO
Norway
Prior art keywords
dimethylbenzylamino
pyridine
dimethyl
imidazo
hydroxyethyl
Prior art date
Application number
NO20063309A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Nordberg
Lars Liljequist
Maria Lindkvist
Ursula Pettersson
Tesfai Sebhatu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063309(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20063309L publication Critical patent/NO20063309L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20063309A 2003-12-18 2006-07-17 Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt NO20063309L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds
PCT/SE2004/001909 WO2005058895A1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.

Publications (1)

Publication Number Publication Date
NO20063309L true NO20063309L (no) 2006-09-14

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063309A NO20063309L (no) 2003-12-18 2006-07-17 Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt

Country Status (24)

Country Link
US (1) US7459463B2 (de)
EP (1) EP1697360B1 (de)
JP (2) JP2007514744A (de)
KR (1) KR20060125803A (de)
CN (1) CN1894246B (de)
AR (1) AR046956A1 (de)
AT (1) ATE499371T1 (de)
AU (1) AU2004299435B2 (de)
BR (1) BRPI0417640A (de)
CA (1) CA2549144A1 (de)
CO (1) CO5721004A2 (de)
DE (1) DE602004031556D1 (de)
ES (1) ES2359829T3 (de)
IL (1) IL175957A0 (de)
MX (1) MXPA06006708A (de)
MY (1) MY140450A (de)
NO (1) NO20063309L (de)
RU (1) RU2376306C2 (de)
SE (1) SE0303451D0 (de)
TW (1) TW200526659A (de)
UA (1) UA84443C2 (de)
UY (1) UY28676A1 (de)
WO (1) WO2005058895A1 (de)
ZA (1) ZA200604633B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682133A1 (de) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo-1,2-a-pyridin-derivate zur behandlung von beschwerdefreiem gastroösophagealem reflux
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
IL312564A (en) 2021-11-05 2024-07-01 Cinclus Pharma Holding Ab Publ Polymorphs of the hydrochloride salt of linfarezan glurate
EP4426693A1 (de) * 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphe des mesylatsalzes von linaprazanglurat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE512531C2 (sv) * 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
EP1368006B1 (de) * 2001-02-13 2006-05-03 AstraZeneca AB Neue formulierung mit modifizierter freisetzung
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Also Published As

Publication number Publication date
JP2007514744A (ja) 2007-06-07
MY140450A (en) 2009-12-31
EP1697360B1 (de) 2011-02-23
TW200526659A (en) 2005-08-16
MXPA06006708A (es) 2006-08-18
UA84443C2 (ru) 2008-10-27
JP2012102143A (ja) 2012-05-31
IL175957A0 (en) 2006-10-05
US7459463B2 (en) 2008-12-02
DE602004031556D1 (de) 2011-04-07
ZA200604633B (en) 2007-04-25
WO2005058895A1 (en) 2005-06-30
RU2376306C2 (ru) 2009-12-20
RU2006123362A (ru) 2008-01-27
CA2549144A1 (en) 2005-06-30
CN1894246A (zh) 2007-01-10
AR046956A1 (es) 2006-01-04
CN1894246B (zh) 2011-06-22
ES2359829T3 (es) 2011-05-27
EP1697360A1 (de) 2006-09-06
UY28676A1 (es) 2005-07-29
AU2004299435A1 (en) 2005-06-30
ATE499371T1 (de) 2011-03-15
HK1095810A1 (en) 2007-05-18
KR20060125803A (ko) 2006-12-06
US20070112021A1 (en) 2007-05-17
SE0303451D0 (sv) 2003-12-18
AU2004299435B2 (en) 2008-04-17
BRPI0417640A (pt) 2007-03-27
CO5721004A2 (es) 2007-01-31

Similar Documents

Publication Publication Date Title
PL1625126T3 (pl) Imidazo- i tiazolopirydyny jako inhibitory kinazy JAK3
WO2004026248A3 (en) Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
MXPA04001940A (es) Tratamiento para desordenes del sistema nervioso central.
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
TW200613243A (en) Novel compounds
WO2007058832A3 (en) Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
TW200730525A (en) Therapeutic agents
MY208077A (en) 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimers disease
TW200420541A (en) Crystalline forms
WO2006053039A3 (en) Hydroxybenzoate salts of metanicotine compounds
NO20061363L (no) Pyrazolo- og imidazo- pyrimidinderivater
MXPA05010883A (es) Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina.
MX2024006688A (es) Metodo de sintesis del compuesto de furoimidazopiridina, forma de cristal del compuesto de furoimidazopiridina, y forma de cristal de la sal del mismo.
WO2004093805A3 (en) Selective spirocyclic glucocorticoid receptor modulators
NO20052124L (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK1406902T3 (da) Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander
PL1869038T3 (pl) Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych
DK1730144T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser
NO973342L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
MY140450A (en) New crystalline forms of 2, 3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo [1,2-a] pyridine-6-carboxamide mesylate salt
SE0100296D0 (sv) New compounds
SE0100297D0 (sv) New compounds
CR20240134A (es) Compuestos de pirazolo[3,4-b]piridina para el tratamiento de enfermedades autoinmunitarias
SE0100295D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application